Facebook
Twitter
Telegram
Report an ErrorSpero Therapeutics Financial Statements 2011-2024 | SPRO
Annual Financial Statements Spero Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
87.5 M | 53 M | 367 M | 329 M | 176 M | 152 M | 32.1 M | - | 49.5 M | - | - | - | - |
Shares |
52.7 M | 37.6 M | 30.9 M | 18.2 M | 18.2 M | 16 M | 2.59 M | - | 13.9 M | - | - | - | - |
Historical Prices |
1.66 | 1.41 | 11.9 | 18.1 | 9.21 | 10.5 | 12.1 | - | - | - | - | - | - |
Net Income |
22.8 M | -46.4 M | -89.8 M | -78.3 M | -60.9 M | -41.7 M | -38.7 M | -25.5 M | -10.2 M | - | - | - | - |
Revenue |
104 M | 53.5 M | 18.3 M | 9.33 M | 18.1 M | 3.97 M | 1.98 M | 335 K | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
21.5 M | -42.2 M | -88 M | -79.1 M | -63.2 M | -42.8 M | -41.7 M | -33.2 M | -13.3 M | - | - | - | - |
Interest Expense |
-14 K | -55 K | -395 K | 432 K | 740 K | 43 K | 1.84 M | 580 K | 174 K | - | - | - | - |
EBITDA |
21.8 M | -41.3 M | -87.3 M | -78.4 M | -62.5 M | -42.4 M | -41.4 M | -32.9 M | -13.5 M | - | - | - | - |
Operating Expenses |
82.3 M | 95.7 M | 106 M | 88.4 M | 81.4 M | 46.8 M | 43.7 M | - | - | - | - | - | - |
General and Administrative Expenses |
25.6 M | 36.5 M | 41.7 M | 21.4 M | 15.6 M | 12.9 M | 10.8 M | 7.22 M | 2.2 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Spero Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
53.5 M | 53 M | 52.7 M | 52.6 M | 52.5 M | 52.5 M | 35.9 M | 33 M | 32.6 M | 32.4 M | 32.1 M | 29.7 M | 29.4 M | 29.3 M | 21.9 M | 20.6 M | 19.6 M | 19.1 M | 18.7 M | 17.7 M | 17.2 M | 17.7 M | 17.5 M | 14.4 M | 14.4 M | 9.27 M | 335 K | 335 K | 330 K | 325 K | 319 K | 313 K | 291 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-12.7 M | - | -3.2 M | -11.9 M | -13.3 M | - | -11.7 M | -28.7 M | -32.8 M | - | -22.5 M | -18.6 M | -19.4 M | - | -18.9 M | -17.5 M | -23.3 M | -25 M | -17.7 M | -13.2 M | -5.1 M | -10.6 M | -10.5 M | -9.96 M | -10.6 M | -13.9 M | -38.7 M | -38.7 M | -38.7 M | -7.21 M | -6.32 M | -6.06 M | -5.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
9.27 M | - | 25.5 M | 2.72 M | 2.07 M | - | 2.01 M | 1.99 M | 2.07 M | - | 3.06 M | 5.15 M | 7.3 M | - | 4 M | 1.73 M | 1.7 M | 696 K | 4.64 M | 2.16 M | 7.72 M | 1.69 M | 658 K | 463 K | 1.15 M | 993 K | 597 K | 249 K | 140 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-14 M | - | -1.93 M | -12.9 M | -14.2 M | - | -11.8 M | -26.1 M | -30.2 M | - | -22.5 M | -18.5 M | -19.4 M | - | -19 M | -18.5 M | -22.8 M | - | -18 M | -13.7 M | -5.7 M | - | -10.9 M | -9.97 M | -10.8 M | - | -9.97 M | -10.2 M | -7.6 M | - | -7.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-14 K | - | -10 K | -6 K | -2 K | - | -23 K | -10 K | -13 K | - | -87 K | -112 K | -118 K | - | 55 K | 889 K | -674 K | - | -135 K | 135 K | 385 K | - | 472 K | 15 K | 172 K | - | 122 K | 402 K | 1.19 M | - | -4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | -14.1 M | - | -11.1 M | -25.6 M | -30 M | - | -22.1 M | -18.2 M | -19.2 M | - | -18.4 M | -18.1 M | -22.6 M | - | -17.1 M | -13.3 M | -5.51 M | - | -10.7 M | -9.78 M | -10.7 M | - | -9.7 M | -10 M | -7.51 M | - | -7.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
23.2 M | - | 27.4 M | 15.6 M | 16.3 M | - | 13.8 M | 28.1 M | 32.3 M | - | 25.6 M | 23.7 M | 26.7 M | - | 23 M | 20.2 M | 24.5 M | 29.5 M | 22.6 M | 15.8 M | 13.4 M | 12.8 M | 11.6 M | 10.4 M | 12 M | 15 M | 10.6 M | 10.4 M | 7.74 M | 9.14 M | 7.91 M | 8.08 M | 8.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
5.92 M | - | 5.71 M | 6.1 M | 7.32 M | - | 6.63 M | 8.05 M | 15.3 M | - | 11.2 M | 9.23 M | 8.3 M | - | 5.31 M | 4.55 M | 4.09 M | - | 4.13 M | 3.78 M | 3.89 M | - | 3.13 M | 3.06 M | 3.04 M | - | 3.65 M | 2.96 M | 1.74 M | - | 1.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency